XYOSTED (testosterone enanthate)

SELF ADMINISTRATION - SUBCUTANEOUS INJECTION

Indications for Prior Authorization: 
  • Indicated for testosterone replacement in adult males for conditions associated with a deficiency or absence of endogenous testosterone (primary hypogonadism (congenital or acquired), and hypogonadotropic hypogonadism (congenital or acquired).
The following criteria must be met for coverage:
  • Patient is 18 years of age or older, AND
  • Diagnosis of hypogonadism confirmed by medical record documentation including lab documentation of morning serum testosterone concentrations below normal range, AND
  • Patient has persistent signs and symptoms (e.g., depressed mood, decreased energy, progressive decrease in muscle mass, osteoporosis, loss of libido) of androgen deficiency (pre-treatment), AND
  • Other reasons for androgen deficiency have been ruled out (e.g. adrenal insufficiency, hypopituitarism), AND
  • Medical justification is provided why patient cannot use both topical testosterone (gel and patch), and testosterone for IM injection, AND
  • Blood pressure is adequately controlled
  • Limited to a 30 day supply per fill
  • Contraindicated in men with carcinomas of the breast or prostate
Dosing:
  • The starting dose of Xyosted is 75 mg, administered subcutaneously in the abdominal region once a week.
Approval: 
  • 1 year

Last review date: May 19, 2020

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone